CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Thursday, May 1st, 2025, at 8:00 a.m. ET to discuss first quarter 2025 financial results. In the most recent ...

2 doses for a primary series and 1 dose as a booster, except the Omicron XBB.1.5 subvariant vaccine. Omicron XBB.1.5 subvariant vaccine doses: The Moderna Spikevax ® Bivalent COVID-19 vaccine ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

who added that the new vaccine also seems to achieve a more durable response than Moderna's first bivalent shot mRNA-1273.211, based on the original SARS-CoV-2 and the Beta variant. With Omicron ...

Apr. 4, 2025 — Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a ...

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.

People are advised to take whichever vaccine they are offered, as both provide protection against severe illness or death. Data from the UK Health Security Agency - based on the 2024 spring ...

Investing.com -- Novavax (NASDAQ:NVAX) stock experienced a 2.4% decline Wednesday following a Wall Street Journal report that the U.S. Food and Drug Administration (FDA) has not met its deadline to ...